Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So TRUE BGC!! PAY TIENCE is coming in. HUGE with $BLEG BLEG
Respectfully,
Maverick
Exactly BGC, YOU said it so simply! I’m just AMAZED how cheap $BLEG is and NOT for long!
This is bottom and I’m having family and friends get in ASAP!
What a DIAMOND HAND GEM $BLEG IS!!
Congrats!
Respectfully,
Maverick
Thanks swim and keep up the EXCELLENT POSTS! I’m getting family and friends in this company ASAP!
$BLEG
BLEG
RESPECTFULLY,
Maverick
Dr. Hamann's ongoing projects include the preclinical development of a small pipeline of natural products with potential applications against cancer, emerging infectious diseases, and neuropsychiatric disorders. His extensive experience and dedication to advancing scientific frontiers make him a valuable addition to Branded Legacy's mission to deliver high-quality, scientifically-backed solutions in the biotech industry. Branded Legacy has already begun supplying the Medical University of South Carolina with samples of mitragynine extract in order to build an effective experimental design for addiction mitigation. Although these trials are arduous, Branded Legacy is committed to doing whatever is necessary to support the process and offer these therapies to the patients who need them as quickly as possible
In other company news, Branded Legacy has just completed a move to a significantly larger facility, accommodating the expanding operations and facilitating enhanced capabilities. The move comes in tandem with the acquisition of millions of dollars worth of state-of-the-art scientific and extraction equipment, solidifying Branded Legacy's commitment to staying at the forefront of innovation in the biotech industry.
The new facility not only provides increased space for research and development but also positions Branded Legacy to meet the rising demand for its innovative wellness solutions. The acquisition of advanced scientific and extraction equipment further strengthens the company's technological infrastructure, supporting its endeavors in drug discovery, pharmaceutical development, and the optimization of natural products.
LITERALLY IN SHOCK,
READ EVERY LINE PEOPLE
Shouting in ALL CAPS!
This DR whose head of our division is A+ and WELL KNOWN!
As BGC says “SUPER GOLDEN!” I say we are “SUPER PLATINUM” with $BLEG!
Read every line!! Takes my breath away!!
GO BLEG $BLEG
RESPECTFULLY,
Maverick
Onward, upward, stair stepping BEAUTY CHART FOR $BLEG biochem!!
SUPER BULLISH!!
BLEG $BLEG
ALL MY OPINION!
Respectfully,
Maverick
Mzasif,
EXACTLY!!
$BLEG wound up, GOLDEN CROSS incoming accumulation / distribution AWESOME
We are better than the other company and soon will surpass it in share price in my opinion!
$KBLB
$BLEG better share structure , management , products and acquisitions than $KBLB!
Share price of $BLEG about to SUPERSONIC MACH 8 to catch KBLB $KBLB in my opinion!
Respectfully,
Maverick
By the way.. keep up the SOLID POSTS, nice enthusiasm and due diligence, much APPRECIATED!
Absolutely and ITS on when we do that Brother!!
$BLEG LONG
RESPECTFULLY,
Maverick
That’s AWESOME! I’m looking forward to when shareholders get the invitation to HEADQUARTERS there in Florida! I will fly out and visit $BLEG headquarters!!
I’m very IMPRESSED with all the due diligence everyone has provided, in a cool, professional manner where future investors may:
Make a informed, educated decision on the knowledge, skills and abilities of our current CEO, BLEG $BLEG company etc.
It’s like working out is what I reference $BLEG to!
Many people go and only workout UPPER BODY, failing to build a base which is STRONG CORE, STRONG GLUTES, QUADS, HAMSTRINGS and calf muscles!
YOU MUST BUILD A STRONG BASE “lower body” before building upper body etc!
$BLEG is building a GIGANTIC STRONG BASE..
Share retirements, lockout agreements with all officers , putting perfect acquisitions together to complement each other..
We just moved from 4,000 to 11,000 square foot manufacturing facility!
As mzasif poster said :
Bring us the WHITE LABEL CONTRACTS!
We have ASSETS, real ASSETS, real products and a A+ MANAGEMENT TEAM, executing a SOLID BASE to grow leaps and bounds each and every sequential quarter in revenues, product offerings and roll it out through ESTABLISHED DISTRIBUTION CHANNELS !
Talk about methodical, precision guided FOCUSSED MANAGEMENT, that first and foremost is one of the MOST SHAREHOLDER FRIENDLY MANAGEMENT IN THE OTC!
LOW FLOAT
NO DILLUTION
$1 million credit line FAVORABLE TERMS
MASSIVE SHARE REDUCTIONS IN A/S, O/S AND small float of 440 million roughly with DEBT being cleared with exception of roughly $21,000 and products selling !
NEW PRODUCTS INBOUND , ASSETS not LIABILITIES...
PROFIT is coming in my opinion in a HUGE WAY!
True example of patience will be PAY TIENCE as your targets of .50 and $1.00 will come with PROVEN PROFITS, as we expand nationwide in my opinion!!
.03-.05 will come quickly and love these prices to have family, friends LOCK UP this NANO FLOAT!
I am SHOCKED at such a deal .002 for such a AMAZING COMPANY, SOLID BUSINESS PLAN and EXECUTING SOLID BASE to go THERMONUCLEAR UTILIZING our incredible talented CEO, employees and relationships to show BRANDED LEGACY is here and operating on all cylinders!
Here’s to SUCCESS for BRANDED LEGACY, and all shareholders!
These prices will be HISTORY very soon!
Proud of my position and continuing to add at these GIFTED LEVELS!
$BLEG
RESPECTFULLY,
Maverick
Sharky,
We are at the right place, right time... plain, pure and simple with $BLEG!
This is MASSIVE news that will just add to the rocketship here!
This is trading so clean, and AMAZED at the silly market cap so far!! The market will correct it to FURTHER UPSIDE as their are so many positives with $BLEG!
See you in copper and silver land soon with $BLEG!
GOLDEN CROSS INCOMING!!!!
All my opinion!
Respectfully,
Maverick
Thanks crazy horse, and GREAT DD! I’ve let the BB crowd and MOMO crowd know of this gem with $BLEG BLEG!
Maverick
Yes!! The 50/200 dMA coming together to create the MOST BULLISH TECHNICAL move...
$BLEG BLEG GOLDEN CROSS
BEAUTIFUL chart, higher highs, higher lows!
INCREDIBLE share structure and SUPER TRANSPARENT CEO!
The crowds will find this and accumulation / distribution looks AMAZING!!
A/D LINE
YUMMY!
This is of course without any additional bullish news !
This company is SEVERELY UNDERVALUED!
Some of my friends in $IFUS IFUS coming over!
My opinion is this BLOWS past .0043 on Golden cross to COPPER with little to no resistance!
This company is worth 1.3 cents just in assets from the companies they have acquired with products on the shelf’s and incredible share reductions!
So many CEO promise to reduce shares etc this CEO is kicking some serious butt and does it through “ TANGIBLE ACTIONS!”
Actions SPEAK louder than words and this CEO has PROVED IT!
$BLEG is doing it correctly and one of the BEST CEO down here doing it!
All my opinion!!
Respectfully,
Maverick
All my opinion
LOCK THIS SUB FLOAT
MY opinion not financial advise.
I feel these million shares for $2,000 will be worth $50,000 in the not to distant future!!
Going to he getting 10k, financials and more updates!!
YES!!
So FUN TO FIND INCREDIBLE DD, and verify it!!
BLEG $BLEG
Absolutely GOLDEN CROSS!!
$BLEG $CBMJ monsters!!
Love Golden crosses!!
Respectfully,
Maverick
BLEG $BLEG .002 BEST SUB out here!
COURTESY of crazy horse!!
ews Branded Legacy, Inc. Significantly Expands Asset Portfolio and Production Capacity Through Successful Acquisition of Sycamore BioPharma, Inc.
https://nz.finance.yahoo.com/news/branded-legacy-inc-significantly-expands-145000503.html
https://sycamorebp.com/our-story/
"Company Prepares for Clinical Trials with Esteemed Addition: Dr. Mark T. Hamann, Endowed Chair of Drug Discovery and Biomedical Sciences at the MUSC College of Pharmacy"
MELBOURNE, Fla., March 12, 2024 /PRNewswire/ -- Branded Legacy (OTC.PK: BLEG), Inc., a trailblazing BioTech holdings company, proudly announces the strategic acquisition of Sycamore BioPharma, Inc, a distinguished developer of plant-based pharmaceuticals. This strategic milestone not only fortifies Branded Legacy's standing as a prominent player in the biotech sector but also secures assets exceeding $2 million, along with key personnel crucial for advancing clinical trials following this successful union.
Renowned for its meticulous development of wellness solutions, ranging from gummies to compression sleeves and pain-relieving topical creams, Sycamore BioPharma has earned acclaim as a prolific product developer. The acquisition brings forth over $500,000 in high-quality, ready-to-sell inventory and aligns seamlessly with Branded Legacy's dedication to quality, authenticity, and a commitment to natural ingredients.
David Oswald, CEO at Branded Legacy, Inc., expresses enthusiasm about the acquisition, stating, "Branded Legacy is thrilled to embrace Sycamore BioPharma into our family of companies. This tactical move not only compliments our existing portfolio, but also brings us several steps closer to our goal of achieving FDA approval for several of our pharmaceutical products.."
The acquisition not only opens new markets for Sycamore BioPharma but also provides access to Branded Legacy's extensive network, enhancing the company's ability to connect with consumers, build brand loyalty, and drive sales growth. It was also a crucial step in securing and maintaining a slew of large white label manufacturing and extraction contracts.
Tyler Stone, President of Sycamore Biopharma, Inc., is also enthusiastic about the acquisition stating, "Branded Legacy brings significant strengths in areas where Sycamore BioPharma was seeing significant challenges. Their network and consumer outreach will undoubtedly drive sales growth of our innovative products and we are proud to be a part of the Branded Legacy network of companies."
The collaboration between Branded Legacy and Sycamore BioPharma is poised to unlock synergies across various business facets. Leveraging Branded Legacy's web properties, brand management, and marketing expertise, the integration aims to maximize the reach and impact of Sycamore BioPharma's groundbreaking wellness solutions. Furthermore, the addition of Dr. Mark Hamann, a PHD holding scientist, to Branded Legacy's roster will enhance efforts in developing novel pharmaceuticals and streamline the FDA approval process, particularly in clinical trials.
Dr. Mark T. Hamann, the newly appointed Director of Clinical Trials at Branded Legacy, brings a wealth of expertise as the Charles and Carol Cooper/SmartState Endowed Chair of Drug Discovery and Biomedical Sciences at the Medical University of South Carolina College of Pharmacy. Holding Adjunct appointments with The University of Maryland's Institute of Marine and Environmental Technology and the Bigelow Marine Laboratory in Maine, Dr. Hamann's distinguished career commenced in GMP pharmaceutical manufacturing at Solvay Pharmaceuticals in Baudette, Minnesota.
Throughout his career, Dr. Hamann has authored over 250 scientific papers, reviews, and book chapters, while mentoring over 100 graduate students, postdoctoral fellows, and visiting scholars. Dr. Hamann's graduate studies led to the discovery of the anticancer agent, kahalalide F, which advanced to clinical trials in collaboration with biotech company PharmaMar. Currently serving as an Associate Editor for Biochimica et Biophysica Acta, General Subjects, Dr. Hamann's research group is actively engaged in the isolation, structure determination, and synthesis optimization of natural products and toxins. Their focus on plant and invertebrate microbiomes aligns with Branded Legacy's commitment to sustainable pharmaceutical development.
Dr. Hamann's ongoing projects include the preclinical development of a small pipeline of natural products with potential applications against cancer, emerging infectious diseases, and neuropsychiatric disorders. His extensive experience and dedication to advancing scientific frontiers make him a valuable addition to Branded Legacy's mission to deliver high-quality, scientifically-backed solutions in the biotech industry. Branded Legacy has already begun supplying the Medical University of South Carolina with samples of mitragynine extract in order to build an effective experimental design for addiction mitigation. Although these trials are arduous, Branded Legacy is committed to doing whatever is necessary to support the process and offer these therapies to the patients who need them as quickly as possible
In other company news, Branded Legacy has just completed a move to a significantly larger facility, accommodating the expanding operations and facilitating enhanced capabilities. The move comes in tandem with the acquisition of millions of dollars worth of state-of-the-art scientific and extraction equipment, solidifying Branded Legacy's commitment to staying at the forefront of innovation in the biotech industry.
The new facility not only provides increased space for research and development but also positions Branded Legacy to meet the rising demand for its innovative wellness solutions. The acquisition of advanced scientific and extraction equipment further strengthens the company's technological infrastructure, supporting its endeavors in drug discovery, pharmaceutical development, and the optimization of natural products.
For more information about Sycamore BioPharma, Inc, please visit: https://sycamorebp.com/
Original Copy of this Press Release:
https://brandedlegacy.com/branded-legacy-inc-elevates-biotech-presence-through-successful-acquisition-of-sycamore-biopharma-inc
For media inquiries, please contact:
Investor Relations & Media Contact
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com
Website: https://brandedlegacy.com/
About Branded Legacy, Inc.:
Branded Legacy, Inc. (OTC: BLEG) is a diversified holdings company focused on the biotech sector. With a commitment to excellence and innovation, Branded Legacy specializes in the development and marketing of cutting-edge products and services, including ventures in biotechnology, digital solutions, and wellness products.
Safe Harbor Statement on Forward-Looking Language:
This release includes forward-looking statements, subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The company disclaims any intention or obligation to update or revise forward-looking statements. Forward-looking statements may be identified by words such as "may," "will," "expect," "believe," "anticipate," "estimate," and similar expressions.
Cision
Cision
View original content:https://www.prnewswire.com/news-releases/branded-legacy-inc-significantly-expands-asset-portfolio-and-production-capacity-through-successful-acquisition-of-sycamore-biopharma-inc-302086890.html
SOURCE Branded Legacy Inc.
BLEG $BLEG .002 BEST SUB stock period!!
ews Branded Legacy, Inc. Significantly Expands Asset Portfolio and Production Capacity Through Successful Acquisition of Sycamore BioPharma, Inc.
https://nz.finance.yahoo.com/news/branded-legacy-inc-significantly-expands-145000503.html
https://sycamorebp.com/our-story/
"Company Prepares for Clinical Trials with Esteemed Addition: Dr. Mark T. Hamann, Endowed Chair of Drug Discovery and Biomedical Sciences at the MUSC College of Pharmacy"
MELBOURNE, Fla., March 12, 2024 /PRNewswire/ -- Branded Legacy (OTC.PK: BLEG), Inc., a trailblazing BioTech holdings company, proudly announces the strategic acquisition of Sycamore BioPharma, Inc, a distinguished developer of plant-based pharmaceuticals. This strategic milestone not only fortifies Branded Legacy's standing as a prominent player in the biotech sector but also secures assets exceeding $2 million, along with key personnel crucial for advancing clinical trials following this successful union.
Renowned for its meticulous development of wellness solutions, ranging from gummies to compression sleeves and pain-relieving topical creams, Sycamore BioPharma has earned acclaim as a prolific product developer. The acquisition brings forth over $500,000 in high-quality, ready-to-sell inventory and aligns seamlessly with Branded Legacy's dedication to quality, authenticity, and a commitment to natural ingredients.
David Oswald, CEO at Branded Legacy, Inc., expresses enthusiasm about the acquisition, stating, "Branded Legacy is thrilled to embrace Sycamore BioPharma into our family of companies. This tactical move not only compliments our existing portfolio, but also brings us several steps closer to our goal of achieving FDA approval for several of our pharmaceutical products.."
The acquisition not only opens new markets for Sycamore BioPharma but also provides access to Branded Legacy's extensive network, enhancing the company's ability to connect with consumers, build brand loyalty, and drive sales growth. It was also a crucial step in securing and maintaining a slew of large white label manufacturing and extraction contracts.
Tyler Stone, President of Sycamore Biopharma, Inc., is also enthusiastic about the acquisition stating, "Branded Legacy brings significant strengths in areas where Sycamore BioPharma was seeing significant challenges. Their network and consumer outreach will undoubtedly drive sales growth of our innovative products and we are proud to be a part of the Branded Legacy network of companies."
The collaboration between Branded Legacy and Sycamore BioPharma is poised to unlock synergies across various business facets. Leveraging Branded Legacy's web properties, brand management, and marketing expertise, the integration aims to maximize the reach and impact of Sycamore BioPharma's groundbreaking wellness solutions. Furthermore, the addition of Dr. Mark Hamann, a PHD holding scientist, to Branded Legacy's roster will enhance efforts in developing novel pharmaceuticals and streamline the FDA approval process, particularly in clinical trials.
Dr. Mark T. Hamann, the newly appointed Director of Clinical Trials at Branded Legacy, brings a wealth of expertise as the Charles and Carol Cooper/SmartState Endowed Chair of Drug Discovery and Biomedical Sciences at the Medical University of South Carolina College of Pharmacy. Holding Adjunct appointments with The University of Maryland's Institute of Marine and Environmental Technology and the Bigelow Marine Laboratory in Maine, Dr. Hamann's distinguished career commenced in GMP pharmaceutical manufacturing at Solvay Pharmaceuticals in Baudette, Minnesota.
Throughout his career, Dr. Hamann has authored over 250 scientific papers, reviews, and book chapters, while mentoring over 100 graduate students, postdoctoral fellows, and visiting scholars. Dr. Hamann's graduate studies led to the discovery of the anticancer agent, kahalalide F, which advanced to clinical trials in collaboration with biotech company PharmaMar. Currently serving as an Associate Editor for Biochimica et Biophysica Acta, General Subjects, Dr. Hamann's research group is actively engaged in the isolation, structure determination, and synthesis optimization of natural products and toxins. Their focus on plant and invertebrate microbiomes aligns with Branded Legacy's commitment to sustainable pharmaceutical development.
Dr. Hamann's ongoing projects include the preclinical development of a small pipeline of natural products with potential applications against cancer, emerging infectious diseases, and neuropsychiatric disorders. His extensive experience and dedication to advancing scientific frontiers make him a valuable addition to Branded Legacy's mission to deliver high-quality, scientifically-backed solutions in the biotech industry. Branded Legacy has already begun supplying the Medical University of South Carolina with samples of mitragynine extract in order to build an effective experimental design for addiction mitigation. Although these trials are arduous, Branded Legacy is committed to doing whatever is necessary to support the process and offer these therapies to the patients who need them as quickly as possible
In other company news, Branded Legacy has just completed a move to a significantly larger facility, accommodating the expanding operations and facilitating enhanced capabilities. The move comes in tandem with the acquisition of millions of dollars worth of state-of-the-art scientific and extraction equipment, solidifying Branded Legacy's commitment to staying at the forefront of innovation in the biotech industry.
The new facility not only provides increased space for research and development but also positions Branded Legacy to meet the rising demand for its innovative wellness solutions. The acquisition of advanced scientific and extraction equipment further strengthens the company's technological infrastructure, supporting its endeavors in drug discovery, pharmaceutical development, and the optimization of natural products.
For more information about Sycamore BioPharma, Inc, please visit: https://sycamorebp.com/
Original Copy of this Press Release:
https://brandedlegacy.com/branded-legacy-inc-elevates-biotech-presence-through-successful-acquisition-of-sycamore-biopharma-inc
For media inquiries, please contact:
Investor Relations & Media Contact
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com
Website: https://brandedlegacy.com/
About Branded Legacy, Inc.:
Branded Legacy, Inc. (OTC: BLEG) is a diversified holdings company focused on the biotech sector. With a commitment to excellence and innovation, Branded Legacy specializes in the development and marketing of cutting-edge products and services, including ventures in biotechnology, digital solutions, and wellness products.
Safe Harbor Statement on Forward-Looking Language:
This release includes forward-looking statements, subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The company disclaims any intention or obligation to update or revise forward-looking statements. Forward-looking statements may be identified by words such as "may," "will," "expect," "believe," "anticipate," "estimate," and similar expressions.
Cision
Cision
View original content:https://www.prnewswire.com/news-releases/branded-legacy-inc-significantly-expands-asset-portfolio-and-production-capacity-through-successful-acquisition-of-sycamore-biopharma-inc-302086890.html
SOURCE Branded Legacy Inc.
Incredible Janet !!
$BLEG
Crazy horse,
Incredible DD sticky post!! This is so UNDERVALUED, and EXCELLENT CEO!
$BLEG belongs multi copper at a minimum once all the $$ comes from OTC traders chasing bitcoin!
SUPER DD POST!
May I copy and paste this great DD post you compiled with credit to you to other boards?
Seems we need to let others know what a gem we have! $$$
Going to pour more of my $FF FF profits in here!
Great work CRAZY HORSE!!
Respectfully,
Maverick
$BLEG
BLEG
BLEG $BLEG
.002
Major company here with lots going for it!
Technicals setting up for 50/200 dMA GOLDEN CROSS!
Undervalued, no dilution , and ready for making higher highs after .0043!!
BLEG
$BLEG
BLEG $BLEG.002
Major company here with lots going for it!
Technicals setting up for 50/200 dMA GOLDEN CROSS!
Undervalued, no dilution , and ready for making higher highs after .0043!!
BLEG
$BLEG
$BLEG GOLDEN CROSS inbound!
Great work! BLEG $BLEG wound up tight!!
Going to EXPLODE upward soon!!
Maverick
Good morning sharky!! Thanks for the INCREDIBLE DUE DILIGENCE!
$BLEG
BLEG
IM in for few million shares and this trades very clean!
INCREDIBLE COMPANY, GOLDEN CROSS COMING, and TRANSPARENT CEO with EXCEPTIONAL LEADERSHIP skills!
This is going to be AMAZING, and stoked to be on board here with some GREAT PEOPLE!
Thanks again for the DD, I slapped the ask as I was bid sitting for a few million and looking forward to the revenue numbers and 10k cling out!!
What amazing acquisitions!
This isn’t staying down here in sub levels for anymore time!
This belongs in copper just with assets and NO PE assigned!
Have SUPER DAY!
Respectfully,
Maverick
BLEG $BLEG
All my opinion!
Nice position! 10,000 shares here $3.43 cost average! I LOVE this potential 35% special dividend and I LOVE reading about LENS from San Diego , Del Mar!
Looks like a FUTURE MULTI BILLION dollar recurring revenue once FDA approval comes!
Institutions own 85% of this and leaves about a 18 million float!
Love when the merger goes thru, their changing the ticker to reflect the business!
Seems like both boards have approved this, now just waiting for the press release that shareholders approved this At 09:00 pacific time!
I LOVE what this is becoming, TALK about ground floor opportunity to MAJOR MULTI BILLION PHARMA for billion plus folks that need this to help their eyes!!
Winner winner and STOKED to get in for dollars in what I feel will be $50 plus once FDA APPROVAL COMES in my opinion!
Not financial advise!
GRPH
$GRPH
RESPECTFULLY,
Maverick
35% special dividend to vote YES this morning!
Let’s rocket this up north of $7 when they announce the shareholders have APPROVED!
All in my humble opinion!
$MEDS SPECIAL “short fry” next week Orion Traders!!
Almost 20% of the FLOAT is short!! Going to be a MASSIVE SHORT SQUEEZE all next week!
Volume proceeds price, and we had low volume day , went up $6 share and 20% float is short!
TIK TOK, see you all north of $50 next week as SHORTS MUST COVER, and PAY DIVIDEND if they don’t cover!
VOLUME comes in, this stock $MEDS will make $HALO look like a walk in the park!
$MEDS also has only 1/4 of the float as $HALO did , and with 20% float short, coupled with FLOAT LOCK, and $8 per share dividend coming MOTHER OF ALL SHORT SQUEEZES is inbound in my humble opinion!
$MEDS on supersonic speed as you can see the FLOAT LOCK with a $1 spread between bid and ask!
Premarket Monday and everyday next week will be SPECTACULAR in my opinion based on the above!
Management set “LONGS” up to be KINGS here and one of the MOST REPUTABLE law firms handled this transaction!
A+
Have super weekend friends and the smell in here is “shorts about to be fried” “deep fried” next week when this $MEDS pulls a SUPERSONIC $HOLO move on 1/4 of the float that $HOLO had!
$8 DIVIDEND COMING !
20% of a 830,000 float SHORTED
FLOAT LOCK
EVERYONE WILL be jumping in to get that dividend and PERFECT ROCKET right here folks will remember..
MEDS $MEDS
ALL my humble opinion, and not financial advise!
Short fry coming next week as shorts MUST COVER, plain, pure , simple!
Respectfully,
Maverick
Buckle up my friend! $MEDS will be $HOLO on steroids next week!
Nano float that is LOCKED, and of all days , Friday showed INCREDIBLE STRENGTH when day and swing traders cash out!
Buckle up 5 point seatbelt harness, and place oxygen mask on!! We’re going SUPERSONIC $MEDS is next week!
I LOVE NANO FLOATS, $8 DIVIDEND per share, coupled with 20% float shorted!
SHORTS MUST COVER!
Grab your popcorn friend, we’re on the ROCKETSHIP RIDE this next week!
All my opinion, not financial advise!
BURN SHORTS!!!
Respectfully,
Maverick
Almost 20% of the FLOAT is short!! Going to be a MASSIVE SHORT SQUEEZE all next week!
Volume proceeds price, and we had low volume day , went up $6 share and 20% float is short!
TIK TOK, see you all north of $50 next week as SHORTS MUST COVER, and PAY DIVIDEND if they don’t cover!
VOLUME comes in, this stock $MEDS will make $HALO look like a walk in the park!
$MEDS also has only 1/4 of the float as $HALO did , and with 20% float short, coupled with FLOAT LOCK, and $8 per share dividend coming MOTHER OF ALL SHORT SQUEEZES is inbound in my humble opinion!
$MEDS on supersonic speed as you can see the FLOAT LOCK with a $1 spread between bid and ask!
Premarket Monday and everyday next week will be SPECTACULAR in my opinion based on the above!
Management set “LONGS” up to be KINGS here and one of the MOST REPUTABLE law firms handled this transaction!
A+
Have super weekend friends and the smell in here is “shorts about to be fried” “deep fried” next week when this $MEDS pulls a SUPERSONIC $HOLO move on 1/4 of the float that $HOLO had!
$8 DIVIDEND COMING !
20% of a 830,000 float SHORTED
FLOAT LOCK
EVERYONE WILL be jumping in to get that dividend and PERFECT ROCKET right here folks will remember..
MEDS $MEDS
ALL my humble opinion, and not financial advise!
Short fry coming next week as shorts MUST COVER, plain, pure , simple!
Respectfully,
Maverick
Great video, nicely done! $MEDS MEDS, see you at $50 plus next week!
Shorts are desperate as they have to cover before the dividend; they will spread misinformation!
Shorts are responsible for covering and if they FAIL , they also have to pay the dividend!
This company set up “longs” with precision!
Keep up EXCELLENT WORK on your charts and videos!
This FLOAT IS LOCKED!
MOTHER OF ALL SHORT SQUEEZES IS COMING and I feel will give $MEDS MEDS a MASSIVE share price appreciation in my humble opinion!
Not financial advise!
GLTU!
Respectfully,
Maverick
Yes! $MEDS MEDS closed at 52 week high on FRIDAY! Going supersonic all the way to the dividend date!! GLTU!!
Respectfully,
Maverick
MEDS $MEDS Very nice stair stepping , coupled with a MOASS incoming with the $8 dividend per share by March 18, with payout March 22!
Riding this puppy since $12.46 and expecting $40-$60 plus share by dividend date!
Float is LOCKED!
Going to be on after burners up to dividend day!
All in my opinion, not financial advise!
Tiny float, and BIG folks accumulating via the charts!
Could pull a $HOLO HOLO price per share appreciation with 1/4 of the float HOLO $HOLO had!
Go MEDS $MEDS
MOTHER OF ALL SHORT SQUEEZES coming by dividend date in my humble opinion!
Respectfully
Maverick
MEDS $MEDS Very nice stair stepping , coupled with a MOASS incoming with the $8 dividend per share by March 18, with payout March 22!
Riding this puppy since $12.46 and expecting $40-$60 plus share by dividend date!
Float is LOCKED!
Going to be on after burners up to dividend day!
All in my opinion, not financial advise!
Tiny float, and BIG folks accumulating via the charts!
Could pull a $HOLO HOLO price per share appreciation with 1/4 of the float HOLO $HOLO had!
Go MEDS $MEDS
MOTHER OF ALL SHORT SQUEEZES coming by dividend date in my humble opinion!
Respectfully
Maverick
MEDS $MEDS Very nice stair stepping , coupled with a MOASS incoming with the $8 dividend per share by March 18, with payout March 22!
Riding this puppy since $12.46 and expecting $40-$60 plus share by dividend date!
Float is LOCKED!
Going to be on after burners up to dividend day!
All in my opinion, not financial advise!
Tiny float, and BIG folks accumulating via the charts!
Could pull a $HOLO HOLO price per share appreciation with 1/4 of the float HOLO $HOLO had!
Go MEDS $MEDS
MOTHER OF ALL SHORT SQUEEZES coming by dividend date in my humble opinion!
Respectfully
Maverick
Peachman- I am very IMPRESSED with the due diligence you have done here! Simply incredible company with a BRIGHT FUTURE!
Thank You for simple, easy to understand due diligence!
IFUS $IFUS is going silver big time and paper is in the cards based on this incredible company!
Keep up SOLID DUE DILIGENCE!
The WORLD COP28 shows the need for companies like IFUS $IFUS to address the food supply issues for their respective populace’s!
Very obvious you have some BASHERS, they are here in my opinion to enjoy the “SHORT FRY” commencing next week!
Nothing better than having SOLID COMPANY, CONTRIBUTING to society , and shorts to add ROCKET FUEL!
All in my opinion
Respectfully,
Maverick
IFUS
$IFUS
Solid ironman9. Excellent due diligence, thanks for providing the links so that future investors can see for themselves.
Perhaps, we can pin this in a sticky. Mods can you put this great dd post in sticky please.
Thanks
Maverick
TVPC
$TVPC
maverick
All in my opinion.
Absolutely! BMXI $BMXI
MAVERICK
ALL IN MY OPINION.
SOLID post ZARDIW— BMXI $BMXI
Onward and upward for this GREAT COMPANY!
Maverick
Yes, churn, burn, onward and upward!
NET PROFIT gold producer!
BMXI
$BMXI
Maverick
All my opinion
Onward and upward!! BMXI $BMXI
VOLUME proceeds price!
All my opinion!
Maverick
GLTA
Sterling,
HUGE THANKS for incredible DD, and taking the time, energy and effort for all! Simply a INCREDIBLE POST, 5 star and here’s to MONI $MONI reaching for the stars with this INCREDIBLE business plan.
Respectfully,
Maverick
MONI $MONI
EXCELLENT SUMMARY!
Maverick
Great idea! a BMXI $BMXI
MAVERICK
Pac-Man .. gobble gobble
Maverick